Glycemic control and hypoglycemia benefits with insulin glargine 300 U/mL (Gla ‐300) extend to people with type 2 diabetes and mild‐to‐moderate renal impairment

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - July 13, 2018 Category: Endocrinology Authors: F. Javier Escalada MD , Serge Halimi MD , Peter A. Senior MBBS PhD , Mireille Bonnemaire MD , Anna MG Cali MD , Lydie Melas ‐Melt , Janaka Karalliedde MBBS MRCP PhD , Robert A. Ritzel MD Source Type: research